Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Diagnostic Model of in-Hospital Mortality in Patients with Acute ST-Segment Elevation Myocardial Infarction: Algorithm Development and Validation

View ORCID ProfileYong Li
doi: https://doi.org/10.1101/2020.05.28.20115485
Yong Li
Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yong Li
  • For correspondence: liyongdoctor@sina.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Coronary heart disease, including ST-segment elevation myocardial infarction (STEMI), remains the main cause of death.

Objectives The objective of our research was to develop and externally validate a diagnostic model of in-hospital mortality in acute STEMI patients.

Methods A total of 2,183 inpatients with acute STEMI from January 2002 to December 2011 in China were admitted for development. The first external validation data set came from 7,485 hospitalized patients with acute STEMI from January 2012 to August 2019 in China. The second external validation data set came from 129,042 hospitalized patients with acute STEMI from January 2016 to December 2018 in the United States. We used two-class multiple logistic regression analysis to analyze the risk factors of in-hospital mortality in the development data set. We developed a diagnostic model of in-hospital mortality and constructed a nomogram. We evaluated the predictive performance of the diagnostic model in the two validation data set by examining the measures of discrimination, calibration, and decision curve analysis (DCA).

Results In the development data set, 61 of the 2,183 participants (2.8%) experienced in-hospital mortality. The strongest predictors of in-hospital mortality were advanced age and cardiogenic shock. Logistic regression analysis showed the difference between the two groups with and without in-hospital mortality in age (odds ratio [OR] 1.0755, 95% CI 1.046016-1.105814; P <.001), and cardiogenic shock (OR 16.48628, 95% CI 9.435111-28.80702; P <.001). We had developed a diagnostic model of in-hospital mortality. The area under the receiver operating characteristic curve (AUC) was 0.8977 (SD 0.0198, 95% CI 0.85894 - 0.93636). We constructed a nomogram based on age and cardiogenic shock. In-hospital mortality occurred in 127 of 7,485 participants (1.7%) in the first validation data set. The AUC was 0.9179(SD 0.0134, 95% CI 0.89158- 0.94424).In-hospital mortality occurred in 14,064 of 129,042 participants (10.9%) in the second validation data set. The AUC was 0.7679(SD 0.0023, 95% CI 0.76346-0.77228).

Conclusion The strongest predictors of in-hospital mortality were advanced age and cardiogenic shock. We had developed and externally validated a diagnostic model of in-hospital mortality in acute STEMI patients. It was found that the discrimination, calibration and DCA of this model were satisfactory.

Trial Registration ChiCTR.org ChiCTR1900027129; http://www.chictr.org.cn/edit.aspx?pid=44888&htm=4.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ChiCTR1900027129

Funding Statement

None.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethic committee approved the study. Approved No. of ethic committee: 2019039X. Name of the ethic committee:Ethics committee of Beijing Anzhen Hospital Capital Medical University. It was a retrospective analysis and informed consent was waived by Ethics Committee of Beijing Anzhen Hospital Capital Medical University.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data are demographic, and clinical characteristics of patients with acute STEMI. AGE= age; ALLAF =atrial fibrillation; AVB =atrioventricular block; CABG =history of coronary artery bypass grafting ; CKD= history of chronic kidney disease; DIE= in-hospital mortality; DM= history of diabetes; HBP = history of hypertension; HCD= history of cerebrovascular disease; HPCI=history of percutaneous coronary intervention; CS = Cardiogenic shock; OMI=history of myocardial infarction; PCI=underwent PCI during hospitalization; S = sex. Data from the National (Nationwide) Inpatient Sample (NIS) data from January 2016 to December 2018 in the United States were used for this study.

https://pan.baidu.com/s/1EECKHEQ8X4jSMSbALMwsSQ

  • List of abbreviations

    AF
    atrial fibrillation
    AIC
    Akanke information criterion
    AMI
    acute myocardial infarction
    AUC
    area under the receiver operating characteristic curve
    AVB
    atrioventricular block
    BIC
    Bayesian information criterion
    CABG
    coronary artery bypass grafting
    CI
    confidence interval
    CKD
    chronic kidney disease
    CS
    cardiogenic shock
    DCA
    decision curve analysis
    PCI
    percutaneous coronary intervention
    MI
    myocardial infarction
    ROC
    receiver operating characteristic
    STEMI
    ST elevation myocardial infarction
    NIS
    National (Nationwide) Inpatient Sample
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
    Back to top
    PreviousNext
    Posted December 29, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Diagnostic Model of in-Hospital Mortality in Patients with Acute ST-Segment Elevation Myocardial Infarction: Algorithm Development and Validation
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Diagnostic Model of in-Hospital Mortality in Patients with Acute ST-Segment Elevation Myocardial Infarction: Algorithm Development and Validation
    Yong Li
    medRxiv 2020.05.28.20115485; doi: https://doi.org/10.1101/2020.05.28.20115485
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Diagnostic Model of in-Hospital Mortality in Patients with Acute ST-Segment Elevation Myocardial Infarction: Algorithm Development and Validation
    Yong Li
    medRxiv 2020.05.28.20115485; doi: https://doi.org/10.1101/2020.05.28.20115485

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Cardiovascular Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (70)
    • Allergy and Immunology (168)
    • Anesthesia (50)
    • Cardiovascular Medicine (451)
    • Dentistry and Oral Medicine (83)
    • Dermatology (55)
    • Emergency Medicine (157)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
    • Epidemiology (5258)
    • Forensic Medicine (3)
    • Gastroenterology (195)
    • Genetic and Genomic Medicine (757)
    • Geriatric Medicine (80)
    • Health Economics (213)
    • Health Informatics (698)
    • Health Policy (358)
    • Health Systems and Quality Improvement (223)
    • Hematology (99)
    • HIV/AIDS (163)
    • Infectious Diseases (except HIV/AIDS) (5867)
    • Intensive Care and Critical Care Medicine (361)
    • Medical Education (104)
    • Medical Ethics (25)
    • Nephrology (83)
    • Neurology (764)
    • Nursing (43)
    • Nutrition (130)
    • Obstetrics and Gynecology (142)
    • Occupational and Environmental Health (231)
    • Oncology (479)
    • Ophthalmology (152)
    • Orthopedics (38)
    • Otolaryngology (95)
    • Pain Medicine (39)
    • Palliative Medicine (20)
    • Pathology (141)
    • Pediatrics (223)
    • Pharmacology and Therapeutics (136)
    • Primary Care Research (96)
    • Psychiatry and Clinical Psychology (862)
    • Public and Global Health (2011)
    • Radiology and Imaging (348)
    • Rehabilitation Medicine and Physical Therapy (158)
    • Respiratory Medicine (285)
    • Rheumatology (94)
    • Sexual and Reproductive Health (74)
    • Sports Medicine (76)
    • Surgery (109)
    • Toxicology (25)
    • Transplantation (29)
    • Urology (39)